Published 1 year ago

Turbine Announces €20-Million Series A behind Digital Cell Platform

Summary by Ground News

Turbine is developing a cell behavior simulation platform to identify beneficial oncology treatments. Turbine's philosophy is that a cell in a patient is dissimilar to a model system perturbed by a CRISPR or chemical screen. A lot of ideas from in vitro models are often not true in patients, the company says.

0 Articles

All

Left

Center

Right

GEN - Genetic Engineering and Biotechnology News…

Turbine Announces €20-Million Series A behind Digital Cell Platform

Turbine—a company developing a cell behavior simulation platform to identify beneficial oncology treatments by combining molecular biology and artificial intelligence (AI)—has announced the closing of a €20-million Series A financing round.

1 year ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.